HEPATITIS B VIRUS. Discovery and Development. Baruch S. Blumberg Fox Chase Cancer Center, Philadelphia PA, USA.

Slides:



Advertisements
Similar presentations
Hepatitis B virus CDC website:
Advertisements

Prevalence of HBV* by Region
Treatment appropriate Normal or minimal hepatitis Chronic hepatitis Normal or inactive hepatitis Progressive fibrosis Cirrhosis HCC HBeAg Anti-HBe HBV.
Health Care in China. Health care system in China The New Rural Co-operative Medical Care System (NRCMCS) is a 2005 initiative to overhaul the healthcare.
Hepatitis B.
Perinatal Hepatitis B Prevention
A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
A Brief Introduction to Epidemiology - VII (Epidemiologic Research Designs: Demographic, Mortality & Morbidity Studies) Betty C. Jung, RN, MPH, CHES.
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
Hepatitis B: Epidemiology
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
Epidemiology of hepatitis B in Ireland Updated August 2014
Epidemiology and Control Programs for HBV Infection. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
A Model for Involving the Community in Hepatitis Healthcare
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Hepatitis C virus epidemiology Varsha Shete Jeni
 Hepatitis B: Decreasing the Burden and Increasing Compliance Abby Wurzel, BSN, RNC Augustina Manuzak, MD, PhD, MPH.
Descriptive Epidemiology
Hepatitis Viruses Chapter 35. Properties of Hepatitis Viruses Six known Hepatitis type A virus (Picornaviridae) Hepatitis type B virus (Hepadnaviridae)
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)
Metabolic Factors / NAFLD on the Natural History of Chronic Hepatitis B or C in Asia Pei-Jer Chen National Taiwan University & Hospital.
Medical Statistics (full English class) Ji-Qian Fang School of Public Health Sun Yat-Sen University.
Viral Hepatitis & Serving Seniors in Community Health Centers Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy U.S. Department of.
Washington D.C., USA, July 2012www.aids2012.org HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong,
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
SECOND ANNUAL WORKSHOP ON GEOETHICAL NANOTECHNOLOGY July 20, 2006 Terasem Green Mountain Center Retreat Lincoln, Vermont CONSCIOUSNESS IN HUMANS AND ELSEWHERE.
Abstract Background: Spontaneous hepatitis B surface antigen (HBsAg) seroclearance is a rare event in patients with chronic hepatitis B virus (HBV) infections.
Harold S. Margolis, M.D. Division of Viral Hepatitis
Hepatitis B Virus 28.
Overview National Hepatitis B Data
WORLD HEPATITIS DAY 2013 Johannesburg, Gauteng 29 th July, 2013 WORLD HEPATITIS DAY 2013 Johannesburg, Gauteng 29 th July, 2013 HEPATITIS B: Post-Vaccination.
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
Measurement Measuring disease and death frequency FETP India.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
What is hepatitis B? Hepatitis B is a virus that infects the liver.
Prevalence of Hepatitis B infection in married women of child bearing age in District Islamabad Dr. Najma Javeed Awan Senior Medical Officer Pakistan Medical.
Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public.
Evaluation framework of viral hepatitis prevention programmes: examples in Italy Paolo Bonanni Department of Public Health University of Florence, Italy.
21th VHPB Meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 Impact of HBV S-gene mutants.
HBV related complications in HIV positive patients during HAART therapy Irina Magdalena Dumitru*, E. Dumitru*, S. Rugina*, Roxana Carmen Cernat**, Simona.
ASTROBIOLOGY SCIENCE CONFERENCE 2006 Washington, DC March 25 – 31, 2006 Viral Evolution HEPATITIS B VIRUS: COMMENTS ON VIRAL AND HUMAN EVOLUTION.
Hepatitis B The Basics David Wong University of Toronto March 2005.
UNIVERSAL IMMUNIZATION OF HEPATITIS B IN ITALY Newborns of HBsAg + mothers at birth Infants of HBsAg - mothers at 3 months of age Children 12 years old.
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
Research and Methodology
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
Hepatitis B Fahad Alanazi.
Isolated Hepatitis B Core Antibody
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
III. Measures of Morbidity: Morbid means disease. Morbidity is an important part of community health. It gives an idea about disease status in that community.
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
Son preference, maternal health care utilization and infant death in rural China Jiajian Chen 1, Zhenming Xie 2, Hongyan Liu 2 1 East-West Center, USA,
Viral hepatitis overview Itodo Ewaoche 27/02/2015.
Clinicaloptions.com/hepatitis Using Virologic and Serologic Tests in the Management of Hepatitis B Diagnose chronic HBV infection When in slideshow mode,
Epidemiological measureas. How do we determine disease frequency for a population?
VIRAL HEPATITIS SUPERVISED BY: Dr Mohammad Rasheed PREPARED BY: Dr Rawan AL Soud.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Hepatitis Viruses.
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Presenter ITODO EWAOCHE
Achieving WHO Recommendations for HCV in the European Union
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
Incidence of notified cases of hepatitis B in Italy. SEIEVA
Presentation transcript:

HEPATITIS B VIRUS. Discovery and Development. Baruch S. Blumberg Fox Chase Cancer Center, Philadelphia PA, USA

HEPATITIS B VIRUS MORPHOLOGY Characteristics Nucleic acid: DNA Classification: hepadnavirus type 1 Serotypes: multiple In vivo replication: reverse transcription in liver and other tissues In vitro propagation: primary hepatocyte culture and transfection by cloned HBV DNA 42 nm 22 nm C HBsAg HBcAgHBV DNA

HBV is one of the most common infections in the world. About 600,000 to 1,000,000 deaths per year are attributable to the diseases associated with HBV.

(H. Margolis, Center for Disease Control. Paper presented at Third International Conference on Therapies for Viral Hepatitis, Maui, 12/12/99) Virus Number Infected (Millions) Low 15% 34 Case Fatality Rate Total Deaths (Millions) High 25% 100% 371 HIV HBV PREDICTED DEATHS FROM PREVALENT CARRIERS OF HIV AND HBV

Age group (years) Mortality per 100,000 py M HBV+M HBV-F HBV+F HBV- MORTALITY BY AGE GENDER AND HBV RESPONSE HAIMEN CITY, CHINA G. Chen, W. Lin, F. Shen, U. Iloeje, T. London and A. Evans Inter. J. of epid. 2004, in print

CONTROL OF HEPATITIS B VIRUS IN CHINA Z.Y. Xu, T.Q. Yan, S.J. Zhao, et al. Shanghai Medical University “Infant HBV immunization has been implemented into public health service in China since 1986… the seropositivity for HBsAg was reduced from 16.3% (879/5397) of historical controls to 1.43% (70/4886) in cross-sectional study and 1.81% (210/11582) in a cohort study.”

 A vaccination program was initiated in 1983 in Afragola, Italy, a community with very high rates of HBV infection and of morbidity and mortality from liver disease (Da Villa, et al., 1992, Da Villa, et al., 1995).  The prevalence of HBsAg in males up to 12 years dropped from 10.5% in 1978 to 0.8 % in 1993 after the vaccination program was in place for ten years.  The prevalence of anti-HBc in dropped from 52.6% to 1.2%.  There was also a drop in the prevalence of HBsAg in the mostly unvaccinated population i.e., males age HBsAg dropped from 17.97% in 1978 to 5.5% in This implies that the reduction of the carrier prevalence in the vaccinated group has an indirect effect on unvaccinated carriers and susceptibles, and suggests that there may an amplification characteristic to the vaccination program. HBV VACCINATION IN ITALY

STUDIES ON TAIWAN Hepatocellular Carcinoma: Average annual incidence in the age range 6-14 fell from 0.7/100,000 in (before vaccination) to 0.36/100,000 in (after vaccination) (p < 0.01) The annual incidence in children aged 6-9 years fell from 0.52/100,000 in those born in (pre-vaccination program), to 0.13/100,00 in those born in , (post-vaccination program) (p<0.001)

The probability of male or female patients in a single hemodialysis unit remaining HBsAg+ after infection. Males have a 68% probability of becoming chronic carriers when first detected HBsAg-, whereas female patients have a 33% chance.

The probability of patients not developing ant-HBs once detected HBsAg+. About 55% of the female patients are likely to eventually develop ant-HBs compared with 30% of males.

Parent’s response To HBV Either parent HBsAg + : anti-HBs – Both parents HBsAg - : anti-HBs – Both parents HBsAg - : either parent anti-HBs + Couples (No.) Live births Male Females 60 (1.8 ± 0.2) 51 (1.8 ± 0.2) 24 (1.6 ± 0.1) 24 (0.7 ± 0.1) 35 (1.2 ± 0.2) 22 (1.4 ± 0.1) Sex ratio 250 (161,429)* 146 (96,230)* 109 (91,131)* PLATI, GREECE. NUMBER OF MALE AND FEMALE LIVE BIRTHS ACCORDING TO THE RESPONSES TO HBV OF PARENTS *In parentheses, the 5 percent confidence limits. Blumberg, B.S. Sex differences in response to Hepatitis B Virus, Arthritis and Rheumatism,22, 1261, 1979

Hepatitis B and Sex Ratio Notes: This table shows sex ratios among the children of carrier and non-carrier parents in four regions. Data were collected by testing married women and, in all cases except for Greenland, their husbands for HBV. Detailed reproductive histories were also collected. The table represents all births to women in those samples, with generally more than one birth to each women. The last two studies (Greece 2 and France) were designed specifically to test the hypothesis that HBV affects offspring sex ratio, and were run after the original theory was expressed. Location Greenland Kar Kar Island Greece 1 Philippines Greece 2 France HBV Status Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative Positive Negative Sons Sex Ratio Daughters From Oster, E. 2005